Veeva Compass
The Data to Action Playbook
for Biopharma Commercialization
Too Many Biopharmas Are Making Key Commercialization Decisions Without a Complete Data Picture
Legacy data is often incomplete, stale, and limited by market basket restrictions and TPAs — slowing down key insights and impacting how quickly therapies can be delivered to patients. This forces companies to make tradeoffs that negatively impact their ability to deliver therapies to the right patients.
An accurate, trustworthy, integrated data ecosystem is essential for quickly and reliably turning data into action. Veeva’s Data Cloud delivers a connected data ecosystem designed to solve commercialization challenges. See real-world customer results below to learn how organizations are leveraging connected, reliable, complete data to drive commercial success and improve patient outcomes.
Segmentation and Targeting
The complexity of modern therapies can make meaningful HCP interactions difficult. Optimizing patient and HCP targeting is essential to success.
With a connected, data-driven engagement strategy, biopharmas can identify high-potential patient populations and HCPs, tailor field activity to the market, and ensure field reps are spending their time efficiently. This accelerates commercialization and ensures biopharmas can bring the right therapies to the right patients, faster.
Oncology (IV Infusion) Understanding Indication Specific Utilization with Projected Data
A global pharma company improved field planning and performance reporting by building patient cohorts across five indications. Unlimited access to retail and non-retail projections improved their understanding of market share.
Chronic Autoimmune Disease Strategic Forecasting for a New Therapeutic Launch
To optimize HCP and patient segmentation and targeting lists pre-launch, this company leveraged patient data and projected prescriber volume data.
Patient Journey
Today’s therapies are more complex than ever. While white-pill retail still exists, it represents an ever-shrinking share of the market, as specialty drugs, infusions, and mixed administration become increasingly common. In 2024, 75% of drugs under development were classed as specialty drugs, and 80% of 2023 novel drug approvals were specialty drugs.
When preparing to launch a therapy for a complex or rare disease, it’s vital to have the most complete data possible. If a biopharma can analyze indicators of future diagnosis and common comorbid symptoms, field teams can leverage predictive modeling to find patients who are likely to be diagnosed before it happens.
Field Insights
Leveraging data to generate patient and HCP insights is only half the battle. To ensure these insights turn into action, it’s crucial to equip field teams with the ability to access, digest, and act on them — without disrupting how they work today.
Delivering the right insights to field teams requires a robust, trustworthy data ecosystem that can be seamlessly integrated with CRM. Key commercial activities like analyzing market access, building patient cohorts and HCP segments, and defining messaging must all flow into metrics and information that field reps can use quickly and comfortably.
Field Activation
In modern healthcare, the market evolves quickly. It’s critical for field reps to be able to act on new information as soon as it becomes available. This becomes even more important if a disease is rare and/or progressive — timely, accurate alerts are critical to reach more patients sooner.
By leveraging a connected data ecosystem that provides timely, accurate data, integrated with tools field reps use every day, biopharmas can ensure programs like alerts and suggestions are delivering relevant information to field reps as soon as possible.
Rare Disease Empowering Rep Call Planning with Veeva Data Cloud + CRM
After struggling to support a rare disease brand used in late-line cases, this biopharma leveraged projected prescriber data to provide the field with actionable HCP insights directly within their workflow.
Rare Disease Accelerating Field Activation Through Daily Field Alerts
A top 20 pharmaceutical company leveraged patient claims and claims lifecycle data to identify 1,600 new prescribers and start 71 new patients on a therapy for a rare disease with no specific diagnosis code.
Rare Disease Predictive Field Alerts with Connected Data
This company leveraged Veeva’s Data Cloud to identify signs and symptoms patients presented with prior to diagnosis, delivering a 7% increase in net new patients and an 8:1 ROI within 6 months.
Veeva data cloud is the modern data foundation for biopharma. Our seamlessly integrated data products help customers overcome the challenges of fragmented, legacy data and accelerate the data to action pipeline.
Our seamlessly integrated data products help customers overcome the challenges of fragmented, legacy data and accelerate the data to action pipeline. By eliminating the complexities of data integration, Data Cloud significantly accelerates insight generation, freeing up valuable time and resources. Veeva’s connected data ecosystem provides biopharmas the ability to learn more about HCPs, move faster in delivering the right message at the right time, and measure overall performance.